Pinho, Paulo Soares deGiribono, Marco2025-03-252025-03-252024-06-11http://hdl.handle.net/10362/181283This thesis investigates the rationale, financial elements, and market effects of Johnson & Johnson's acquisition of Abiomed Inc. in 2022. The acquisition was facilitated in large part by Abiomed's innovative Impella heart pump technology, which fit in well with Johnson & Johnson's plan to control the rapidly expanding cardiovascular device market. The $16.6 billion deal, including the use of contingent value rights to align shareholder interests, is examined in the report. It also looks at post-acquisition technology integration and regulatory issues, highlighting the wider implications for future advancements in healthcare and competitive market positioning.engMergers & AcquisitionContingent value rightCovid-19 pandemicCorporate strategyCardiovascular healthHealthcare innovationFinancial analysisTechnological integrationmaster thesis203865758